Symbol Name ID |
Nts
neurotensin MGI:1328351 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+ Leprtm1.1Chua/Leprtm1.1Chua Ntstm1(cre)Mgmj/Nts+ involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N |
abnormal nervous system electrophysiology | J:176657 |
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+ Ntstm1(cre)Mgmj/Nts+ involves: 129S4/SvJaeSor * C57BL/6 * FVB |
normal nervous system phenotype | J:176657 |
Leprtm1.1Chua/Leprtm1.1Chua Ntstm1(cre)Mgmj/Nts+ involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB |
abnormal locomotor activation | J:176657 |
abnormal neuron physiology | J:176657 | |
abnormal percent body fat/body weight | J:176657 | |
abnormal synaptic dopamine release | J:176657 | |
decreased lean body mass | J:176657 | |
decreased locomotor activity | J:176657 | |
decreased oxygen consumption | J:176657 | |
decreased response to leptin | J:176657 | |
increased body weight | J:176657 | |
increased circulating leptin level | J:176657 | |
increased gonadal fat pad weight | J:176657 | |
increased total body fat amount | J:176657 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|